2000
DOI: 10.1053/jpsu.2000.7768
|View full text |Cite
|
Sign up to set email alerts
|

The effects of a pediatric unilateral inguinal hernia clinical pathway on quality and cost

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 7 publications
0
8
0
Order By: Relevance
“…There have been several recent examples in the pediatric surgical literature demonstrating their safety and efficacy. [4][5][6] In 2000, Stylianos and the APSA Trauma Committee published evidence-based guidelines for the care of hemodynamically stable children with isolated liver or spleen injuries. 7 This was first shown to be safe and efficacious in a multicenter trial published in 2002.…”
Section: Discussionmentioning
confidence: 99%
“…There have been several recent examples in the pediatric surgical literature demonstrating their safety and efficacy. [4][5][6] In 2000, Stylianos and the APSA Trauma Committee published evidence-based guidelines for the care of hemodynamically stable children with isolated liver or spleen injuries. 7 This was first shown to be safe and efficacious in a multicenter trial published in 2002.…”
Section: Discussionmentioning
confidence: 99%
“…For inguinal hernia, the cost of surgical management may be reduced by better selection of patients [16]. Furthermore, systematic pathological analysis of inguinal hernia sacs increased the cost of surgery (by $21.41 per specimen) [17].…”
Section: Analysis and Findings Of Ees In General Surgerymentioning
confidence: 99%
“…In half of the study sample (49.6%), the inclusion and exclusion criteria of patients were obscure and difficult to relate to the population’s characteristics. According to our findings, only 12 retrospective studies (10.4%) controlled for selection bias by matching, out of which three studies matched a random sample from a clinical pathway group with controls from the pre‐pathway period group [25,30,48,50,58,79,81,107,110,111,122,129].…”
Section: Discussionmentioning
confidence: 99%
“…In relation to the internal and external validity of the studies in the sample, our analysis revealed several factors that influenced the quality of clinical pathway evaluation. Most studies in our sample concerned non-randomly selected small patient populations without a power analysis [19,23,25,36,52,54,56,58,59,61,76,81,[86][87][88]91,99,107,111,118,122,123,126,128].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation